Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage I Esophageal Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01333033
What this trial is testing

PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal Cancer
Alliance for Clinical Trials in Oncology 257
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)UnknownNCT00509561
What this trial is testing

Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Wales Cancer Trials Unit 259
Testing effectiveness (Phase 2)Ended earlyNCT00093652
What this trial is testing

Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer

Who this might be right for
Esophageal Cancer
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00281736
What this trial is testing

Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer

Who this might be right for
Esophageal CancerPrecancerous Condition
Roswell Park Cancer Institute 60
Early research (Phase 1)Study completedNCT00496860
What this trial is testing

Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic Malignancies

Who this might be right for
Progressive Metastatic Malignancies
Altor BioScience 26
Early research (Phase 1)Study completedNCT01391208
What this trial is testing

Esophageal Protocol for Detection of Neoplasia in the Digestive Tract

Who this might be right for
Barrett EsophagusEsophageal Adenocarcinoma
University of Michigan 25
Large-scale testing (Phase 3)Ended earlyNCT02551458
What this trial is testing

Comparison of Systematic Surgery Versus Surveillance and Rescue Surgery in Operable Oesophageal Cancer With a Complete Clinical Response to Radiochemotherapy

Who this might be right for
Epidermoid Carcinoma orAdenocarcinoma of the Thoracic Oesophagus orAdenocarcinoma of the Oesogastric Junction (Siewert Type I or II)+1 more
Centre Hospitalier Universitaire Dijon 188
Testing effectiveness (Phase 2)Study completedNCT00021047
What this trial is testing

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Who this might be right for
Esophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Ended earlyNCT01705340
What this trial is testing

Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionHER2-positive Breast CancerMale Breast Cancer+9 more
National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT01671774
What this trial is testing

Safety and Activity of IMAB362 in Combination With Zoledronic Acid and Interleukin-2 in CLDN18.2-positive Gastric Cancer

Who this might be right for
CLDN18.2-positive Gastric AdenocarcinomaCLDN18.2-positive Adenocarcinoma of the Gastroesophageal JunctionCLDN18.2-positive Adenocarcinoma of Esophagus
Astellas Pharma Global Development, Inc. 29
Testing effectiveness (Phase 2)Looking for participantsNCT03539822
What this trial is testing

Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

Who this might be right for
Gastric CancerEsophageal AdenocarcinomaHepatocellular Carcinoma+1 more
Anwaar Saeed 117
Testing effectiveness (Phase 2)Study completedNCT00711412
What this trial is testing

Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Northwestern University 44
Large-scale testing (Phase 3)Active Not RecruitingNCT03801876
What this trial is testing

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

Who this might be right for
Clinical Stage I Esophageal Adenocarcinoma AJCC v8Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8+10 more
NRG Oncology 300
Early research (Phase 1)Study completedNCT00423254
What this trial is testing

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Who this might be right for
OvarianMelanomaRenal+20 more
Mannkind Corporation 12
Early research (Phase 1)Study completedNCT00004257
What this trial is testing

Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer

Who this might be right for
Esophageal Cancer
Albany Medical College
Testing effectiveness (Phase 2)Study completedNCT00009880
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach

Who this might be right for
Esophageal CancerGastric Cancer
Radiation Therapy Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00003137
What this trial is testing

Irinotecan in Treating Patients With Advanced Cancer of the Stomach

Who this might be right for
Esophageal CancerGastric Cancer
Alliance for Clinical Trials in Oncology 70
Testing effectiveness (Phase 2)Ended earlyNCT02530437
What this trial is testing

Taladegib, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Localized Esophageal or Gastroesophageal Junction Cancer

Who this might be right for
Gastroesophageal Junction AdenocarcinomaStage IB Esophageal Adenocarcinoma AJCC v7Stage II Esophageal Adenocarcinoma AJCC v7+4 more
M.D. Anderson Cancer Center 7
Early research (Phase 1)Study completedNCT00003548
What this trial is testing

Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

Who this might be right for
Cancer
NYU Langone Health 20
Next Page